ArticleOncoTargets and therapy2016

Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole.

Shengliang Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.